| - Industry | - Sector | Mr. Craig R. Cooper BEC, L.L.B. CEO | ASX Exchange | AU0000420739 ISIN |
| Australia Country | - Employees | - Last Dividend | 17 Feb 2022 Last Split | - IPO Date |
CONNEQT Health Limited is an innovative health technology company that excels in the design, manufacture, and marketing of advanced medical devices with a concentrated emphasis on cardiovascular health management. The company’s flagship technology is rooted in the patented SphygmoCor vascular biometric platform, which allows for noninvasive measurement of central hemodynamics and arterial stiffness. This technology equips healthcare providers and patients with clinically validated vascular biomarkers, including central aortic pressures. Targeting various markets, CONNEQT offers products suitable for consumers as well as hospitals, clinics, research institutions, and pharmaceutical companies on a global scale, particularly in the Americas, Europe, and Asia Pacific.
By integrating medical devices with digital solutions and wearables, CONNEQT Health is transforming how healthcare is delivered. The company emphasizes home health monitoring, decentralized clinical trials, and remote patient care, thereby positioning itself at the forefront of the expanding longevity and preventive cardiovascular health market. With a comprehensive approach that provides clinical-grade insights for both consumers and health professionals, CONNEQT addresses critical aspects of early detection and management of hypertension, cardiovascular disease, and associated vascular disorders.